Contact
Please use this form to send email to PR contact of this press release:
Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research and Development Day
TO:
Please use this form to send email to PR contact of this press release:
Vical Highlights Successful Outcome of Phase 1 Trial of VL-2397 Novel Antifungal During its Research and Development Day
TO: